Capricor Therapeutics, Inc. Profile Avatar - Palmy Investing

Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an…

Biotechnology
US, San Diego [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of CAPR's Analysis
CIK: 1133869 CUSIP: 14070B309 ISIN: US14070B3096 LEI: - UEI: -
Secondary Listings
CAPR has no secondary listings inside our databases.